Intervention

Cytoreductive Surgery

ClinicalTrials.gov intervention label

Clinical trials1
Recruiting0
Common conditions25
Lead sponsors shown1

Common conditions

Malignant Abdominal Neoplasm1Malignant Pelvic Neoplasm1Recurrent Colon Carcinoma1Recurrent Desmoplastic Small Round Cell Tumor1Recurrent Fallopian Tube Carcinoma1Recurrent Gastric Carcinoma1Recurrent Liposarcoma1Recurrent Malignant Mesothelioma1Recurrent Ovarian Carcinoma1Recurrent Primary Peritoneal Carcinoma1Recurrent Rectal Carcinoma1Recurrent Rhabdomyosarcoma1Recurrent Sarcoma1Refractory Colon Carcinoma1Refractory Desmoplastic Small Round Cell Tumor1Refractory Fallopian Tube Carcinoma1Refractory Gastric Carcinoma1Refractory Liposarcoma1Refractory Malignant Mesothelioma1Refractory Ovarian Carcinoma1Refractory Primary Peritoneal Carcinoma1Refractory Rectal Carcinoma1Refractory Rhabdomyosarcoma1Refractory Sarcoma1Resectable Liposarcoma1

Trial status mix

TERMINATED1

Phase mix

EARLY_PHASE11

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.